Samsrita Labs Limited (BOM:539267)

Market Cap	280.05M -33.3%
Revenue (ttm)	181.33K
Net Income	-80.73M
EPS	-3.56
Shares Out	22.75M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	7,652
Open	11.71
Previous Close	12.31
Day's Range	11.70 - 12.25
52-Week Range	10.15 - 25.27
Beta	0.19
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 12, 2026

About Samsrita Labs

Samsrita Labs Limited operates as a biopharmaceutical company in India. It offers DNA, RNA, and chromosomal-based tests for oncology, pharmacogenomics, infectious diseases, genetic disorders, transplantation typing, and prenatal and pre-implantation genetic diagnostics; and quantitative/real-time polymerase chain reaction (qPCR), multiplex ligation-dependent probe amplification (MLPA), Sanger and Next Generation Sequencing (NGS), karyotype, and fluorescence in-situ hybridization analysis. The company is also involved in the stem cell research a...

• Industry: Commercial Physical and Biological Research
• Founded: 1996
• Employees: 5
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 539267

Financial Performance

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Sep 16, 2026

Data Sources Report a data error